 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Bristol-Myers Squibb
RETA
conference date: October 31, 2024 @ 5:00 AM Pacific Time
Bristol Myers Squibb: Growth Plans and Q2 2022 Results [July 29, 2022] at Seeking Alpha
Bristol Myers Squibb Q2 2021 Shows Strenth And Value [July 29, 2021] at Seeking Alpha
Bristol Myers Squibb Offers Growth With A Safe Dividend [June 23, 2020] at Seeking Alpha
Bristol-Myers Squibb On Roll With Opdivo Results [October 3, 2019] at Seeking Alpha
Bristol-Myers Squibb (BMY) is a large-cap biotechnology and pharmaceutical company.
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALLO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BLRX |
| BLUE |
| BMY |
| CDTX |
| CLDX |
| FATE |
| GILD |
| GLYC |
| ILMN |
| INO |
| IONS |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| SAGE |
| SANA |
| SYRS |
| TSVT |
| VRTX |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2024 William P. Meyers